Edmond de Rothschild Holding’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Edmond de Rothschild Holding’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-315	Closed	-$10.6K	–	581
2025 Q2	$10.6K	Hold	315	–	–	﹤0.01%	526
2025 Q1	$10K	Hold	315	–	–	﹤0.01%	535
2024 Q4	$12.2K	Hold	315	–	–	﹤0.01%	565
2024 Q3	$14.2K	Hold	315	–	–	﹤0.01%	592
2024 Q2	$13.2K	Hold	315	–	–	﹤0.01%	629
2024 Q1	$14.3K	Hold	315	–	–	﹤0.01%	635
2023 Q4	$14.6K	Hold	315	–	–	﹤0.01%	641
2023 Q3	$12.8K	Hold	315	–	–	﹤0.01%	650
2023 Q2	$15.3K	Hold	315	–	–	﹤0.01%	660
2023 Q1	$15.5K	Hold	315	–	–	﹤0.01%	665
2022 Q4	$15.9K	Hold	315	–	–	﹤0.01%	726
2022 Q3	$16K	Hold	315	–	–	﹤0.01%	753
2022 Q2	$15K	Hold	315	–	–	﹤0.01%	744
2022 Q1	$19K	Hold	315	–	–	﹤0.01%	747
2021 Q4	$25K	Sell	315 -1,750	-85%	-$147K	﹤0.01%	764
2021 Q3	$183K	Buy	2,065 +315	+18%	+$29.5K	﹤0.01%	551
2021 Q2	$174K	Buy	1,750 +387	+28%	+$34.3K	﹤0.01%	549
2021 Q1	$123K	Buy	+1,363	New	+$135K	﹤0.01%	544

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Edmond de Rothschild Holding's GNOM Position: Q3 2025 in Review

Edmond de Rothschild Holding sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 315 shares — an estimated $10.6K sold.

Edmond de Rothschild Holding first reported a position in GNOM in Q1 2021 and held it in 18 quarters. The position peaked at $183K in Q3 2021. 43 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

Edmond de Rothschild Holding reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Edmond de Rothschild Holding sold 315 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $10.6K.
Edmond de Rothschild Holding first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 18 quarters.
Edmond de Rothschild Holding's Global X Genomics & Biotechnology ETF position peaked at $183K in Q3 2021.
43 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2025, filed 13 Nov 2025.